โ
๐ ๐๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ
โข Revenue: $5.14B (+72.1% YoY)
โข GAAP EPS: $0.49 vs. -$0.53 YoY
โข Net Income: $167.3M vs. -$137.5M YoY
โข Operating Income: $178.0M vs. -$129.3M YoY
โข Adjusted EBITDA: $206.9M vs. -$101.5M YoY
โข Medical Loss Ratio: 84.0% vs. 88.5% YoY (-450 bps)
โข SG&A Expense Ratio: 14.0% vs. 17.5% YoY (-350 bps)
โข Total Members: 2.69M (+27.2% YoY)
โ
๐ฏ ๐๐ฎ๐ข๐๐๐ง๐๐ (๐ ๐๐๐, ๐๐๐ข๐ฌ๐๐)
โข Revenue: $19.0Bโ$19.3B (prior $18.7Bโ$19.0B)
โข Operating Income: $850Mโ$950M (prior $600Mโ$800M)
โข Medical Loss Ratio: 80.5%โ81.5% (prior 81.0%โ82.0%)
โข SG&A Expense Ratio: 15.1%โ15.6% (prior 15.6%โ16.1%)
โ
๐ ๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
โข Revenue growth driven by higher membership and premium rate increases
โข Q3 revenue included a $250M benefit from updated risk adjustment estimates
โข Medical Loss Ratio improved 450 bps YoY, reflecting stronger underwriting and disciplined pricing
โข SG&A expense ratio improved 350 bps, supported by operating leverage and cost management
โข Returned to profitability with a $307M YoY improvement in operating income
โข Nine-month revenue surged 65% to $14.67B, with operating income reaching $1.27B vs. a $62.6M loss YoY
โข Nine-month adjusted EBITDA reached $1.35B vs. $28.0M YoY
โข Raised FY26 operating income guidance midpoint by $200M to $900M
โข Management expects further market share gains and margin expansion in 2027
โ
๐ฌ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐จ๐ฆ๐ฆ๐๐ง๐ญ๐๐ซ๐ฒ
โOscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time.โ โ CEO Mark Bertolini